Core Points - The company, Kaili Medical, announced that two executives, Huang Yibo and Li Hao, have increased their shareholdings in the company, indicating confidence in its future performance [1] - The shareholding increase involved Huang Yibo purchasing 160,000 shares, representing 0.04% of the total share capital, and Li Hao acquiring 300,000 shares, accounting for 0.07% of the total share capital [1] - As of the announcement, Kaili Medical's market capitalization stands at 12.3 billion yuan [1] Company Summary - Kaili Medical's revenue composition for the year 2024 is entirely from the medical device industry, with a 100% contribution from this sector [1] - The company is actively engaging in share buybacks by its executives, which may reflect a positive outlook on its stock performance [1]
开立医疗:黄奕波、李浩合计增持公司股份46万股